thymine has been researched along with Cardiac Failure in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "VEGF promoter polymorphisms +405 and -460 were examined in 596 CHF patients enrolled in the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF) study and in 187 healthy controls." | 5.11 | The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy. ( De Boer, RA; Hall, AS; van der Meer, P; van der Steege, G; van Veldhuisen, DJ; Voors, AA; White, HL, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van der Meer, P | 1 |
| De Boer, RA | 1 |
| White, HL | 1 |
| van der Steege, G | 1 |
| Hall, AS | 1 |
| Voors, AA | 1 |
| van Veldhuisen, DJ | 1 |
1 trial available for thymine and Cardiac Failure
| Article | Year |
|---|---|
The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy.
Topics: Adrenergic beta-Antagonists; Case-Control Studies; Cohort Studies; Cytosine; Female; Follow-Up Studi | 2005 |